111 related articles for article (PubMed ID: 28121669)
1. Human papillomavirus antibody response following HAART initiation among MSM.
Combes JD; Clifford GM; Egger M; Cavassini M; Hirsch HH; Hauser C; Calmy A; Schmid P; Bernasconi E; Günthard HF; Franceschi S; Waterboer T; Scherrer AU;
AIDS; 2017 Feb; 31(4):561-569. PubMed ID: 28121669
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy.
Leng CY; Low HC; Chua LL; Chong ML; Sulaiman H; Azwa I; Roberts JM; Kamarulzaman A; Rajasuriar R; Woo YL
HIV Med; 2017 May; 18(5):321-331. PubMed ID: 27649852
[TBL] [Abstract][Full Text] [Related]
5. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
7. HAART slows progression to anal cancer in HIV-infected MSM.
Duncan KC; Chan KJ; Chiu CG; Montaner JS; Coldman AJ; Cescon A; Au-Yeung CG; Wiseman SM; Hogg RS; Press NM
AIDS; 2015 Jan; 29(3):305-11. PubMed ID: 25686679
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
Combes JD; Pawlita M; Waterboer T; Hammouda D; Rajkumar T; Vanhems P; Snijders P; Herrero R; Franceschi S; Clifford G
Int J Cancer; 2014 Nov; 135(10):2453-61. PubMed ID: 24729277
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with men.
Sharma R; Efird JT; Chein A; Holly EA; Krajden M; Berry JM; Darragh TM; Jay N; Palefsky JM
J Acquir Immune Defic Syndr; 2013 Dec; 64(5):479-87. PubMed ID: 24231786
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in Australian homosexual men.
Poynten IM; Jin F; Templeton DJ; Prestage GP; Donovan B; Pawlita M; Fairley CK; Garland S; Grulich AE; Waterboer T
Sex Transm Dis; 2012 Sep; 39(9):726-32. PubMed ID: 22902671
[TBL] [Abstract][Full Text] [Related]
11. An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study.
Beachler DC; Pinto LA; Kemp TJ; Nyitray AG; Hildesheim A; Viscidi R; Schussler J; Kreimer AR; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):496-502. PubMed ID: 29475967
[No Abstract] [Full Text] [Related]
12. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.
Robbins HA; Waterboer T; Porras C; Kemp TJ; Pawlita M; Rodriguez AC; Wacholder S; Gonzalez P; Schiller JT; Lowy DR; Esser M; Matys K; Poncelet S; Herrero R; Hildesheim A; Pinto LA; Safaeian M
Hum Vaccin Immunother; 2014; 10(10):2965-74. PubMed ID: 25483632
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
[TBL] [Abstract][Full Text] [Related]
15. Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men.
van der Snoek EM; van der Ende ME; den Hollander JC; Schutten M; Neumann HA; van Doornum GJ
Sex Transm Dis; 2012 Jul; 39(7):495-500. PubMed ID: 22695316
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis.
Lang Kuhs KA; Anantharaman D; Waterboer T; Johansson M; Brennan P; Michel A; Willhauck-Fleckenstein M; Purdue MP; Holcátová I; Ahrens W; Lagiou P; Polesel J; Simonato L; Merletti F; Healy CM; Kjaerheim K; Conway DI; Macfarlane TV; Thomson P; Castellsagué X; Znaor A; Black A; Huang WY; Krogh V; Trichopoulou A; Bueno-de-Mesquita HB; Clavel-Chapelon F; Weiderpass E; Ekström J; Riboli E; Tjønneland A; Sánchez MJ; Travis RC; Hildesheim A; Pawlita M; Kreimer AR
Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):683-9. PubMed ID: 25623733
[TBL] [Abstract][Full Text] [Related]
18. HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men.
Alberts CJ; van Rooijen MS; Prins M; Pawlita M; Schim van der Loeff MF; Waterboer T
Sex Transm Dis; 2015 Mar; 42(3):129-34. PubMed ID: 25668644
[TBL] [Abstract][Full Text] [Related]
19. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.
Bertisch B; Franceschi S; Lise M; Vernazza P; Keiser O; Schöni-Affolter F; Bouchardy C; Dehler S; Levi F; Jundt G; Ess S; Pawlita M; Kovari H; Wandeler G; Calmy A; Cavassini M; Stöckle M; Clifford G;
Am J Epidemiol; 2013 Sep; 178(6):877-84. PubMed ID: 23900553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
